PulseAugur
EN
LIVE 09:27:44
中文(ZH) 韩国上半年生物制药出口额料达45亿美元,创历史同期新高

South Korea's biopharmaceutical exports hit record high in H1

South Korea's biopharmaceutical exports are projected to reach a record high of $4.5 billion in the first half of the year, marking a 15.3% increase compared to the same period last year. This surge represents a significant portion of the country's total pharmaceutical exports, which are expected to grow from $4.9 billion in 2023 to $7.6 billion by 2025. The strong performance indicates a robust growth trend in the South Korean biopharmaceutical sector. AI

IMPACT Indicates strong growth in a key global industry sector, potentially impacting AI applications in drug discovery and development.

RANK_REASON Significant growth in a national industry sector reaching a historical high. [lever_c_demoted from significant: ic=1 ai=0.4]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

South Korea's biopharmaceutical exports hit record high in H1

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    South Korea's biopharmaceutical exports expected to reach $4.5 billion in the first half of the year, a record high for the same period.

    韩国政府周三公布的数据显示,今年上半年韩国生物制药产品出口额预计将创下历史新高。根据韩国食品药品安全部的数据,该产品类别今年前六个月的出口额预计为45亿美元,同比增长15.3%,在上半年价值52亿美元的全部药品出口中占比达86.5%。韩国生物制药出口额从2023年的49亿美元增长至2025年的76亿美元。如果这一趋势持续下去,该部预计今年将创下历史新高。(新浪财经)